نتایج جستجو برای: 177lu dotatate

تعداد نتایج: 1456  

2017
Margret Schottelius Theresa Osl Andreas Poschenrieder Frauke Hoffmann Seval Beykan Heribert Hänscheid Andreas Schirbel Andreas K. Buck Saskia Kropf Markus Schwaiger Ulrich Keller Michael Lassmann Hans-Jürgen Wester

Purpose: Based on the clinical relevance of the chemokine receptor 4 (CXCR4) as a molecular target in cancer and on the success of [68Ga]pentixafor as an imaging probe for high-contrast visualization of CXCR4-expression, the spectrum of clinical CXCR4-targeting was expanded towards peptide receptor radionuclide therapy (PRRT) by the development of [177Lu]pentixather. Experimental design: CXCR4 ...

2015
Samaneh Zolghadri Hassan Yousefnia Amir Reza Jalilian Yousef Fazaeli

Due to interesting therapeutic properties of 177Lu and tumor avidity of tetraphenyl porphyrins (TPPs), 177Lu-tetraphenyl porphyrin was developed as a possible therapeutic compound. 177Lu of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu2O3 sample with thermal neutron flux of 4 × 1013 n.cm-2.s-1. Tetraphenyl porphyrin was synthetized and labeled with 177Lu. Radiochemica...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2015
Sune Folke Pedersen Benjamin Vikjær Sandholt Sune Høgild Keller Adam Espe Hansen Andreas Ettrup Clemmensen Henrik Sillesen Liselotte Højgaard Rasmus Sejersten Ripa Andreas Kjær

OBJECTIVE A feature of vulnerable atherosclerotic plaques of the carotid artery is high activity and abundance of lesion macrophages. There is consensus that this is of importance for plaque vulnerability, which may lead to clinical events, such as stroke and transient ischemic attack. We used positron emission tomography (PET) and the novel PET ligand [(64)Cu] [1,4,7,10-tetraazacyclododecane-N...

2014
Johnnie J. Orozco Ethan R. Balkin Ted A. Gooley Aimee Kenoyer Donald K. Hamlin D. Scott Wilbur Darrell R. Fisher Mark D. Hylarides Mazyar Shadman Damian J. Green Ajay K. Gopal Oliver W. Press John M. Pagel

Radioimmunotherapy (RIT) for treatment of hematologic malignancies has primarily employed monoclonal antibodies (Ab) labeled with 131I or 90Y which have limitations, and alternative radionuclides are needed to facilitate wider adoption of RIT. We therefore compared the relative therapeutic efficacy and toxicity of anti-CD45 RIT employing 90Y and 177Lu in a syngeneic, disseminated murine myeloid...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015
Ezgi Ilan Mattias Sandström Cecilia Wassberg Anders Sundin Ulrike Garske-Román Barbro Eriksson Dan Granberg Mark Lubberink

UNLABELLED Peptide receptor radionuclide therapy (PRRT) is a promising treatment for patients with neuroendocrine tumors, giving rise to improved survival. Dosimetric calculations in relation to PRRT have been concentrated to normal organ dosimetry in order to limit side effects. However, the relation between the absorbed dose to the tumor and treatment response has so far not been established....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید